在基础研究和临床研究中,用于视网膜基因治疗的腺相关病毒载体
1State Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Suzhou, China.
Frontiers in medicine
|December 18, 2023
概括
使用腺相关病毒 (AAV) 载体的基因治疗为治疗视网膜退行性疾病提供了有前途的方法. 选择正确的AAV载体和注射途径是有效将基因传递到特定眼睛细胞的关键.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 视网膜退行性疾病会导致不可逆转的视力丧失.
- 基因疗法是各种视网膜疾病的新兴治疗策略.
- 基因相关病毒 (AAV) 载体非常适合用于视网膜基因疗法,因为安全性和有效性.
研究的目的:
- 为提供AAV载体的概述,用于将基因转移到眼细胞中.
- 为了突出显示眼睛中特定细胞类型的合适的AAV载体.
- 确定基于AAV的视网膜基因疗法的进展和未满足需求.
主要方法:
- 在眼部基因转移中使用的AAV载体的审查.
- 对不同类型的眼细胞 (RPE,光受体,RGC,米勒细胞等) 的AAV载体适应性的分析. ) 的情况.
- 考虑用于向基因传递的注射途径和AAV变体.
主要成果:
- 在视网膜应用中,AAV载体在安全性和基因表达稳定性方面具有优势.
- 特定的AAV载体和施用方法适合针对不同的眼细胞群体.
- 在识别各种视网膜细胞类型的有效AAV载体方面取得了进展.
结论:
- 选择AAV载体和给药途径对于成功的眼部基因治疗至关重要.
- 需要进行进一步的研究,以解决对视网膜疾病的AAV载体开发的未满足需求.
- AAV载体具有治疗广泛的视网膜疾病治疗的巨大潜力.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...